Get the Stockscreener App
3.105
8.19%
0.235
After Hours:
3.05
-0.055
-1.77%
Inventiva Adr stock is traded at $3.105, with a volume of 2.84M.
It is up +8.19% in the last 24 hours and down -19.56% over the past month.
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.
See More
Previous Close:
$2.87
Open:
$2.975
24h Volume:
2.84M
Relative Volume:
0.93
Market Cap:
$733.51M
Revenue:
$4.90M
Net Income/Loss:
$-399.99M
P/E Ratio:
-1.093
EPS:
-2.8407
Net Cash Flow:
$-122.90M
1W Performance:
-6.48%
1M Performance:
-19.56%
6M Performance:
-45.91%
1Y Performance:
-43.24%
1-Day Range:
$2.935
$3.18
1-Week Range:
$2.82
$3.35
52-Week Range:
$2.82
$7.9825
Inventiva Adr Stock (IVA) Company Profile
Compare IVA vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
3.105 | 733.51M | 4.90M | -399.99M | -122.90M | -2.8407 |
VRTX
Vertex Pharmaceuticals Inc
|
508.74 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.35 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.50 | 53.23B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.30 | 42.34B | 5.76B | 514.49M | 1.10B | 4.4813 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-26 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-19-26 | Initiated | Truist | Buy |
| Jan-28-26 | Initiated | Barclays | Overweight |
| Jan-12-26 | Initiated | Leerink Partners | Outperform |
| Jan-07-26 | Resumed | UBS | Buy |
| Nov-06-25 | Initiated | Wolfe Research | Outperform |
| Sep-03-25 | Resumed | H.C. Wainwright | Buy |
| Aug-27-25 | Initiated | Piper Sandler | Overweight |
| Feb-21-25 | Initiated | TD Cowen | Buy |
| Nov-12-24 | Initiated | UBS | Neutral |
| Oct-27-23 | Initiated | Canaccord Genuity | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-19-23 | Upgrade | Societe Generale | Sell → Buy |
| Mar-17-23 | Initiated | Stifel | Buy |
| Nov-15-22 | Downgrade | Societe Generale | Buy → Sell |
| Mar-08-21 | Downgrade | Societe Generale | Buy → Sell |
| Aug-05-20 | Initiated | ROTH Capital | Buy |
| Aug-04-20 | Initiated | Guggenheim | Buy |
| Aug-04-20 | Initiated | Stifel | Buy |
View All
Inventiva Adr Stock (IVA) Latest News
Inventiva S.A. (IVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alpha Tau Medical Ltd. (DRTS) Stock Price & News - Syfe
ADARx Pharmaceuticals, Inc. (ADRX) Stock Price & News - Syfe
Inventiva Q2 Earnings Call Highlights - TradingView
Inventiva (IVA) held €166.1 million in cash but says its resources fall short of 12 months of needs. - Stock Titan
IVA - Finviz
CapEx per share of Inventiva SA ADR – HAM:6IVA - TradingView
6IVA Stock Price and Chart — HAM:6IVA - TradingView
6IVA Stock Price and Chart — HAM:6IVA - TradingView
VALN Stock Price, Quote & News - Syfe
IVA Price History for Inventiva S.A. ADR Stock - Barchart.com
Inventiva S.A.American Depository Shares Stock 12‑Month Price Target Cut to $14.35, Implies 212% Upside - TradingView
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Average Rating of "Buy" by Brokerages - MarketBeat
Inventiva (IVA) Slides 1.15% to $4.75 as Shares Approach Critical SupportVOLD Alert - careplusvn.com
Inventiva: MASH Is Becoming A Combination Market Before Lanifibranor Arrives (NASDAQ:IVA) - Seeking Alpha
Inventiva (IVA) Dips 2.5% as Biotech Sector Weighs on SentimentFund Manager Survey - careplusvn.com
Inventiva S.A. Sponsored ADR $IVA Stake Reduced by Ally Bridge Group NY LLC - MarketBeat
Inventiva (IVA) Dips 2.5% as Biotech Sector Weighs on SentimentMutual Fund Flow - dars.gov.et
Inventiva (IVA) Dips 2.5% as Biotech Sector Weighs on SentimentCalendar Spread Trade - www.dars.gov.et
Inventiva (IVA) Shares Edge Lower as Key Support Levels Come into FocusTriple EMA - careplusvn.com
Inventiva (IVA) Short Interest & Short Float | Updated Jul 2026 $IVA - MarketBeat
Inventiva (IVA) Gains Ground: Testing Resistance After Modest UptickTime Weighted Price - careplusvn.com
Inventiva (IVA) Gains 1.6% as Shares Test Key Resistance ZoneInvestment Factor - careplusvn.com
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Cantor Fitzgerald Initiates Inventiva SA ADR at Overweight - Moomoo
Cantor Fitzgerald Initiates Inventiva SA ADR at Overweight - Moomoo
Inventiva (IVA) Announces Issuance of New EIB Warrants, Completes EIB Warrant Restructuring - Yahoo Finance
After plunging 30.8% in 4 weeks, here's why the trend might reverse for Inventiva (IVA) - MSN
Inventiva (IVA) Gains 3.2% as Shares Test Key Resistance ZoneLow Volume Node - dars.gov.et
Inventiva S.A.American Depository Shares Stock 12‑Month Price Target Raised to $15.69, Implies 257% Upside - tradingview.com
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
6IVA Forecast — Price Target — Prediction for 2027 - TradingView
After plunging 30.8% in 4 weeks, here's why the trend might reverse for Inventiva (IVA) - MSN
Inventiva S.A. (IVA) is One of the Best Stocks Under $10 Offering More Than 50% Upside - Yahoo Finance
After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Inventiva (IVA) - Yahoo Finance
A2P796 Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (LSX:A2P796) - TradingView
6IVA Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (LS:A2P796) - TradingView
A2P796 Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (NASDAQ:IVA) - TradingView
6IVA Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (NASDAQ:IVA) - TradingView
Inventiva SA ADR Actuals & Estimates (NASDAQ:IVA) - TradingView
IVA News | INVENTIVA SAADR (NASDAQ:IVA) - ChartMill
Claret Capital Partners participates in €130m financing for Inventiva to support Phase 3 development - GlobeNewswire Inc.
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing - GlobeNewswire Inc.
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
Inventiva Adr Stock (IVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.81%
0.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):